Showing 21-30 of 346 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| ABX: An AI-Driven Automated Bolus Extension to Eliminate Meal Announcements in Hybrid Closed-Loop Systems | Rector & Visitors of the University of Virginia | Anas El Fathi | Improving Lives | 01-March-2026 to 28-February-2031 | $997.185,02 |
| Nano-encapsulated microparticulate drug delivery platforms for decreasing islet graft immunogenicity | University of Miami | Dhanashree Surve | Cures | 01-March-2026 to 28-February-2029 | $274.010,00 |
| Optimizing Approaches to Type 1 Diabetes Prediction and Intervention in the Adult Autoantibody Positive Population | Trustees of Indiana University | Emily Sims | Cures | 01-February-2026 to 31-January-2029 | $691.694,00 |
| ACTin1 for DD: Developing and Testing a Digital Single Session Acceptance and Commitment Therapy Intervention for Type 1 Diabetes Distress | Duke University | Max Roberts | Improving Lives | 01-April-2026 to 31-March-2029 | $241.710,00 |
| Engineering Treg Signaling to Develop an Effective Cell Therapy for Type 1 Diabetes | The Regents of the University of California, San Francisco | Roberto Castro-Gutierrez | Cures | 01-March-2026 to 28-February-2029 | $285.000,00 |
| Rewiring Cellular Microenvironments with Synthetic Circuits for Subcutaneous Islet Transplantation | Georgia Tech Research Corporation | Alexander Vlahos | Cures | 01-March-2026 to 28-February-2031 | $992.325,06 |
| Protective Interventions against Loss of Function and Destruction of β cells in Type 1 Diabetes. | Icahn School of Medicine at Mount Sinai | Romina Bevacqua | Cures | 01-March-2026 to 28-February-2031 | $999.999,00 |
| Optimized bone marrow conditioning and tolerance assays to advance cell-based therapies for diabetes | Stanford University | Stephan Ramos | Cures | 01-March-2026 to 28-February-2029 | $285.000,00 |
| Targeting the Autoimmune Germinal Center Axis in Type 1 Diabetes | Vanderbilt University Medical Center (VUMC) | Rachel Bonami | Cures | 01-March-2026 to 29-February-2028 | $600.000,00 |
| Chemical Perturb-seq to identify small molecules controlling the maturation and survival on human beta cells | Weill Medical College of Cornell University | Xiaoshan Zhang | Cures | 01-March-2026 to 28-February-2029 | $256.285,00 |